Sugi Predict

Sugi Predict / Compounds / SCHEMBL4251502

SCHEMBL4251502

SCHEMBL4251502

Cc1ccc(NC(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1N

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 9/20 0.61
▸ HDAC1 Q13547 3/20 0.59
▸ HDAC3 O15379 2/20 0.59
▸ HDAC4 P56524 2/20 0.59
▸ HDAC7 Q8WUI4 2/20 0.59
▸ HDAC2 Q92769 2/20 0.59
▸ HDAC10 Q969S8 2/20 0.59
▸ HDAC11 Q96DB2 2/20 0.59
▸ HDAC8 Q9BY41 2/20 0.59
▸ HDAC6 Q9UBN7 2/20 0.59
▸ HDAC9 Q9UKV0 2/20 0.59
▸ HDAC5 Q9UQL6 2/20 0.59
▸ RAF1 P04049 2/20 0.59
▸ ARAF P10398 1/20 0.59
▸ BTK Q06187 2/20 0.58
▸ MAPT P10636 4/20 0.57
▸ LMNA P02545 2/20 0.57
▸ GAA P10253 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ KDR P35968 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13472574 0.95 MAPT (0.60) BRAFHDAC1HDAC3HDAC4HDAC7
SCHEMBL3299352 0.86 KCNQ3 (0.57) BRAFBTKMAPTLMNARAB9A
SCHEMBL28806101 0.86 BRAF (0.59) BRAFHDAC1HDAC3HDAC4HDAC7
SCHEMBL14146746 0.86 KDR (0.74) HDAC1HDAC8HDAC6KDR
SCHEMBL4251497 0.86 BRAF (0.68) BRAFHDAC1HDAC3HDAC4HDAC7
SCHEMBL2679303 0.85 MAPT (0.55) BRAFRAF1BTKMAPTLMNA
SCHEMBL1265375 0.84 MEN1 (0.69) MAPTLMNARAB9AMEN1NPC1
SCHEMBL27682667 0.83 BRAF (0.56) BRAFHDAC1HDAC3HDAC4HDAC7
SCHEMBL12518236 0.83 KIT (0.51) BRAFRAF1MAPTRAB9AMEN1
SCHEMBL3300398 0.83 MAPT (0.54) BRAFRAF1MAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105250-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-04-23 — — US claimed
EP-1841431-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM, LLC (BM) 2007-10-10 — — EP claimed
WO-2006081172-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2006-08-03 — — WO claimed
CN-105801584-B Novel aryl amide Raf kinase and its preparation method and application 中国药科大学 2019-03-05 — — CN disclosed
CN-105801584-A Novel aromatic amide Raf kinase inhibitors and preparation method and application thereof 中国药科大学 2016-07-27 — — CN disclosed
CN-103387576-A Aramide Raf kinase inhibitor based on purine structure and preparation method and application thereof UNIV CHINA PHARMA 2013-11-13 — — CN disclosed
US-20090105250-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-04-23 — — US disclosed
EP-1841431-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM, LLC (BM) 2007-10-10 — — EP disclosed
WO-2006081172-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2006-08-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105250-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS ABL1, BCR, PDGFRB BRAF 8/4885HDAC1 3354/4885HDAC3 2760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.